A biopharmaceutical therapeutics company to Incorporate Wearable and Invisible Contactless Digital Health Technologies in Parkinson’s Disease Clinical Trial
A clinical stage biopharmaceutical company announced a collaboration with Innovation Lab companies that focused on using wearable and invisible contactless digital health technology to improve monitoring and data collection for Parkinson’s disease clinical trials.
Currently, monitoring and data collection in Parkinson’s disease clinical trials combine subjective patient-reporting tools such as diaries and questionnaires with periodic neurological and mobility assessments in a clinical setting that only capture a specific moment in time. Unfortunately, this approach fails to give a full, real-time picture of disease progression and the impact of a patient’s daily experience with Parkinson’s symptoms.
The use of these digital technologies is expected to collect an unbiased, objective, and continuous measure of disease impact on function that will help develop more effective therapies.